T he increasing use of GLP-1 medications for weight loss has triggered a corresponding surge in body lift surgeries, as ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Popular weight loss drugs such as Wegovy and Zepbound have shown incredible success in clinical trials. But in the real world ...

When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, one method led to much more weight loss.

Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 ...

Bariatric surgery is associated with a significantly greater long-term weight loss than treatment with GLP-1 receptor agonists, a new head-to-head real-world study finds.

Real-world cost barriers and insurance denials contribute to early discontinuation of injectable glucagon-like peptide-1 (GLP ...

New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...

GLP-1 drugs show promise in diabetes management, offering heart and kidney benefits, but also highlight the need for ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections ...

Here are eight takeaways from our conversation with Kessler about using the GLP-1 drugs, and the changing landscape of weight loss. Foods high in salt, sugar and fat that are "highly palatable and ...